UK Markets closed

Eargo, Inc. (EAR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2500-0.0300 (-2.34%)
At close: 04:00PM EDT
1.2400 -0.01 (-0.80%)
After hours: 07:54PM EDT

Eargo, Inc.

1600 Technology Drive
6th Floor
San Jose, CA 95110
United States
650 351 7700

IndustryMedical Devices
Full-time employees238

Key executives

NameTitlePayExercisedYear born
Mr. Christian GormsenCEO, Pres & Director662.17kN/A1976
Mr. Adam LaponisChief Financial Officer398.5kN/A1976
Mr. William H. BrownieChief Operating Officer398.5kN/A1967
Mr. Daniel ShenCo-Founder and Chief Clinical & Science OfficerN/AN/AN/A
Mr. Mark ThorpeChief Accounting OfficerN/AN/A1968
Mr. Fernando CruzChief Information OfficerN/AN/AN/A
Mr. Nicholas S. LaudicoSr. VP of Corp. Strategy & Investor RelationsN/AN/AN/A
Ms. Christy La PierreChief Legal Officer & Sec.N/AN/AN/A
Ms. Tricia BurchellVP of People Operations & TalentN/AN/AN/A
Mr. Michael PerrySr. VP of EngineeringN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Eargo, Inc., a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.

Corporate governance

Eargo, Inc.’s ISS governance QualityScore as of 1 May 2022 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.